Fighting Back for Consumers Against Big Business

Get Your Free Case Evaluation
Search our site for information on our cases: drugs, medical devices, injuries, and side effects.

What is Consumer Safety Watch?

Consumer Safety Watch is a consumer safety advocate that helps fight for individuals and families that have been injured as a result of negligent products, medical devices or drugs and pharmaceutical products.

The big pharmaceutical firms, medical device makers, insurance companies and corporations have millions to pay attorneys, investigators, and doctors to protect their financial interests. It is not uncommon for these companies to intentionally choose profits over safety and human lives. It is nearly impossible for an individual or family to take on these companies alone. Those affected need an organization that protect their rights and help victims of corporate or pharmaceutical abuse get the compensation they deserve. At Consumer Safety Watch, individuals are connected with top legal representation to meet their needs, almost always at no cost out of pocket to the victims or their families.

We are currently accepting compensation claims on behalf of AFFF firefighting foam cancer, thyroid disease, Hashimoto’s disease and ulcerative colitis victims; Tepezza hearing loss victims; Asbestos mesothelioma and lung cancer victims; Talcum Powder ovarian cancer and mesothelioma victims; Camp Lejeune toxic water victims; 3M earplug hearing loss and tinnitus victims; Paraquat Parkinson’s Disease victims; for individuals who suffered farm loan discrimination from the USDA; and more.

Top Cases

Latest News

Featured Article
New Hearing Loss Warnings Added to Tepezza Drug Label
As Tepezza maker Horizon Therapeutics faces dozens of lawsuits alleging that the thyroid eye disease (TED) drug causes permanent hearing loss in users, the U.S. Food and Drug Administration (FDA) has finally approved a hearing impairment warning for the Tepezza label. The new warning alerts patients to the fact that Tepezza “may cause severe hearing impairment including hearing loss, which in some cases may be permanent,” and urges providers to “assess patients’ hearing before, during, and after treatment with TEPEZZA and consider the benefit-risk of treatment with patients.”
Read More
Rate This Service
4.7/5 - (102 votes)